Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

CollPlant Biotechnologies (CLGN) Restructuring Costs (2018 - 2019)

Historic Restructuring Costs for CollPlant Biotechnologies (CLGN) over the last 2 years, with Q3 2019 value amounting to $323000.0.

  • CollPlant Biotechnologies' Restructuring Costs fell 3764.48% to $323000.0 in Q3 2019 from the same period last year, while for Sep 2019 it was $323000.0, marking a year-over-year decrease of 3764.48%. This contributed to the annual value of $228000.0 for FY2020, which is 617.28% down from last year.
  • CollPlant Biotechnologies' Restructuring Costs amounted to $323000.0 in Q3 2019, which was down 3764.48% from $294000.0 recorded in Q2 2019.
  • In the past 5 years, CollPlant Biotechnologies' Restructuring Costs ranged from a high of $1.9 million in Q1 2018 and a low of $294000.0 during Q2 2019